- $27.93bn
- $29.69bn
- $6.07bn
- 94
- 27
- 91
- 81
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,564 | 4,634 | 5,255 | 5,826 | 6,065 |
Cost of Revenue | |||||
Gross Profit | 2,483 | 2,609 | 3,007 | 3,363 | 3,594 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,079 | 4,095 | 4,460 | 4,838 | 4,932 |
Operating Profit | 485 | 539 | 795 | 987 | 1,134 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 337 | 1,508 | 678 | 874 | 991 |
Provision for Income Taxes | |||||
Net Income After Taxes | 268 | 1,452 | 614 | 755 | 866 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 739 | 1,613 | 608 | 755 | 866 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 670 | 1,544 | 574 | 755 | 866 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.608 | 3.92 | 1.74 | 2.13 | 2.58 |
Dividends per Share |